Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia

被引：0
|
作者：
Yakout, T. [1 ]
Mosaad, G. [2 ]
Namour, A. [2 ]
Malek, R. [3 ]
Khorshid, O. [2 ]
机构：
[1] Cairo Oncol Ctr, Cairo, Egypt
[2] Natl Canc Inst, Cairo, Egypt
[3] Cairo Univ, Fac Med, Cairo, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3652
引用
收藏
页码：S852 / S852
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients
    Khorshid, Ola
    Namour, Alfred Elias
    El-Gammal, Mosaad M.
    Mahmoud, Tarek Yakout
    Fortpied, Catherine
    Abdel-Malek, Raafat
    Ramadan, Safaa
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2015, 7
  • [2] Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia.
    Mohamed, Tarek Yakout
    El Gammal, Mosaad
    Namour, Alfred Elias
    Malek, Raafat Ragaie Abdel
    Khorshid, Ola
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Comparative study between intravenous and subcutaneous administration of cladribine in treatment of hairy cell leukemia patients
    Nehad M. Tawfik
    Aml Soliman Nasr
    Comparative Clinical Pathology, 2012, 21 (6) : 1269 - 1274
  • [4] Outcomes of intravenous and subcutaneous cladribine administration in patients with hairy cell leukemia: A systematic review and meta-analysis
    Basit, Jawad
    Zaheer, Zaofashan
    Khan, Muhammad Hammad
    Fatima, Maurish
    Taj, Sobaan
    Akbar, Usman Ali
    Rehman, Mohammad Ebad Ur
    Saeed, Sajeel
    Vikash, Sindhu
    Ramesh, Nithya
    Shahab, Asna
    Shahid, Muhammad
    Komel, Aqsa
    Irshad, Umer
    Tabassum, Shehroze
    Naeem, Aroma
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Efficacy and safety of cladribine in hairy cell leukemia - a retrospective single center experience
    Bohn, J-P
    Wanner, D.
    Gastl, G.
    Steurer, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 50 - 51
  • [6] Cladribine in hairy cell leukemia
    Belani, Rajesh
    Saven, Alan
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 20 (05) : 1109 - +
  • [7] Efficacy of Cladribine Combine With Rituximab versus Cladribine Alone in the Treatment of Hairy Cell Leukemia: A Retrospective Single-Center Study
    Acar, Ibrahim Halil
    Guvenc, Birol
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S323 - S324
  • [8] Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency
    Gozzetti, Alessandro
    Bacchiarri, Francesca
    Raspadori, Donatella
    Sicuranza, Anna
    Sammartano, Vincenzo
    Bocchia, Monica
    REVIEWS ON RECENT CLINICAL TRIALS, 2023, 18 (04) : 300 - 303
  • [9] Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings
    Lad, Deepesh P.
    Malhotra, Pankaj
    Khadwal, Alka
    Prakash, Gaurav
    Suri, Vikas
    Kumari, Savita
    Jain, Sanjay
    Das, Reena
    Varma, Neelam
    Varma, Subhash
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1428 - 1430
  • [10] PROGNOSTIC MARKERS OF TREATMENT EFFICACY AND OUTCOME IN PATIENTS WITH HAIRY CELL LEUKEMIA RECEIVING SUBCUTANEOUS CLADRIBINE IN THE ICGHCL2004 PROTOCOL
    Forconi, F.
    Cencini, E.
    Sozzi, E.
    Fiore, F.
    Zaccaria, A.
    Piccin, A.
    Martinelli, G.
    Morabito, F.
    Pierri, I.
    Masini, L.
    Rigacci, L.
    Gallamini, A.
    Rossi, D.
    Bertoni, F.
    Pileri, S. A.
    Lauria, F.
    ANNALS OF ONCOLOGY, 2011, 22 : 173 - 174
12345